Advisor Group Holdings, Inc. Adma Biologics, Inc. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 66,172 shares of ADMA stock, worth $1.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,172

Previous 9,186 620.36%

Holding current value

$1.03 Million

Previous $167,000 620.96%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$17.6 - $24.51 $1 Million - $1.4 Million	56,986 Added 620.36%	66,172 $1.2 Million
Q2 2025 Aug 13, 2025	SELL	$17.6 - $24.51 $1.03 Million - $1.44 Million	-58,561 Reduced 86.44%	9,186 $167,000
Q1 2025 May 12, 2025	BUY	$15.44 - $20.61 $774,547 - $1.03 Million	50,165 Added 285.32%	67,747 $1.34 Million
Q4 2024 Jun 06, 2025	SELL	$15.62 - $22.62 $888,934 - $1.29 Million	-56,910 Reduced 84.0%	10,837 $185,000
Q4 2024 Feb 07, 2025	BUY	$15.62 - $22.62 $60,668 - $87,856	3,884 Added 28.35%	17,582 $301,000
Q3 2024 Nov 13, 2024	SELL	$11.21 - $20.03 $699,100 - $1.25 Million	-62,364 Reduced 81.99%	13,698 $273,000
Q2 2024 Aug 13, 2024	BUY	$5.98 - $11.18 $203,188 - $379,874	33,978 Added 80.74%	76,062 $850,000
Q1 2024 May 10, 2024	BUY	$4.4 - $6.74 $2,288 - $3,504	520 Added 1.25%	42,084 $277,000
Q4 2023 Feb 12, 2024	BUY	$3.08 - $4.52 $3,440 - $5,048	1,117 Added 2.76%	41,564 $187,000
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $19,549 - $25,972	5,634 Added 16.18%	40,447 $144,000
Q2 2023 Aug 10, 2023	SELL	$3.12 - $4.22 $5,784 - $7,823	-1,854 Reduced 5.06%	34,813 $128,000
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $2,230 - $2,867	741 Added 2.06%	36,667 $121,000
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $4,059 - $5,720	2,000 Added 5.9%	35,926 $87,000
Q2 2022 Aug 10, 2022	BUY	$1.43 - $2.2 $40,969 - $63,030	28,650 Added 543.03%	33,926 $67,000
Q1 2022 May 04, 2022	SELL	$1.28 - $1.83 $9,085 - $12,989	-7,098 Reduced 57.36%	5,276 $9,000
Q3 2021 Nov 05, 2021	SELL	$1.13 - $1.65 $1,694 - $2,475	-1,500 Reduced 10.81%	12,374 $14,000
Q2 2021 Aug 02, 2021	SELL	$1.51 - $2.07 $15,652 - $21,457	-10,366 Reduced 42.76%	13,874 $23,000
Q1 2021 May 13, 2021	SELL	$1.67 - $2.95 $33,323 - $58,864	-19,954 Reduced 45.15%	24,240 $42,000
Q4 2020 Feb 10, 2021	BUY	$1.8 - $2.56 $17,566 - $24,983	9,759 Added 28.34%	44,194 $86,000
Q3 2020 Nov 12, 2020	BUY	$2.04 - $3.74 $60,047 - $110,086	29,435 Added 588.7%	34,435 $82,000
Q2 2020 Aug 14, 2020	BUY	$2.42 - $3.29 $12,100 - $16,450	5,000 New	5,000 $15,000

Others Institutions Holding ADMA

# of Institutions

396

Shares Held

191M

Call Options Held

2.08M

Put Options Held

1.56M

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.04B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Adma Biologics, Inc. Transaction History